FDA.reportPublic FDA data

NDC 73377-068 - Atovaquone

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
73377-068
Package NDCs from labels
73377-068-01, 73377-068-02
Manufacturer
AX Pharmaceutical Corp
Effective date
2020-09-10
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Atovaquone - AX Pharmaceutical CorpAX Pharmaceutical Corp2020-09-10BULK INGREDIENT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73377-068-01Atovaquone500 g in 1 JARPOWDER5001
73377-068-02Atovaquone100 g in 1 JARPOWDER1001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73377-068ATOVAQUONE POWDER [AX PHARMACEUTICAL CORP]12 package rows20200911_43bc7032-b18a-45a0-94d6-d2b077c84daa.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 29 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Atovaquone and Proguanil HydrochlorideATOVAQUONE AND PROGUANIL HYDROCHLORIDEBluePoint Laboratoriesad25ab65-42aa-48f6-b5ed-247f3685d5bf2026-09-03Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
Atovaquone and Proguanil HydrochlorideATOVAQUONE AND PROGUANIL HYDROCHLORIDEBryant Ranch Prepacke4ff57f7-07af-4872-ac3a-c521e098ccfe2026-07-27Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
Atovaquone Oral SuspensionATOVAQUONEKVK-Tech, Inc.b31ff20a-c363-4be0-9bc0-3081c163b63c2026-06-16Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
ATOVAQUONEATOVAQUONEAvKARE54423fee-da60-25dc-e063-6294a90a25522026-06-14Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONECamber Pharmaceuticals, Inc.2445304e-4b4e-4358-b098-31f3c49c52ef2026-06-10Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
MALARONEATOVAQUONE AND PROGUANIL HYDROCHLORIDEGlaxoSmithKline LLCfc22e8d8-3bfb-4f70-a599-dd81262a48872026-06-10Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
atovaquoneATOVAQUONEGlenmark Pharmaceuticals Inc., USA9045ba6f-938e-4717-bfa2-a3efe52f04cd2026-05-06Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEPAI Holdings, LLC dba PAI Pharmadf6086d3-6100-422a-bf23-e9610027749b2026-04-30Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
ATOVAQUONEATOVAQUONEAmneal Pharmaceuticals LLCb7398fcf-522a-488a-8dd6-051561f628042026-04-29Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
Atovaquone and Proguanil Hydrochloride PediatricATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRICGlenmark Pharmaceuticals Inc.,USA4b80d087-eaa7-448f-967e-344de7f164362026-04-24Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
MEPRONATOVAQUONEGlaxoSmithKline LLCb426b6bf-f07e-4580-97ae-dfca1ddf5b8f2026-03-20Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
Atovaquone Oral SuspensionATOVAQUONEKesin Pharma Corporation4a2e2c4b-85aa-9b30-e063-6294a90a7bd92026-02-06Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEGolden State Medical Supply, Inc.ddbfe1a9-df9b-79b0-e053-2995a90acc9b2025-12-17Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
Atovaquone and Proguanil HydrochlorideATOVAQUONE AND PROGUANIL HYDROCHLORIDEGolden State Medical Supply, Inc.152433eb-1341-9cc0-e063-6394a90a14812025-12-11Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEBionpharma Inc.bff4f4fc-6307-f414-e053-2a95a90ac0de2025-12-04Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEChartwell Governmental & Specialty RX, LLC.e6770b85-54f8-4969-af02-7d81586be7612025-11-07Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEAmerican Health Packaging1a8a43a2-bc26-4ee5-aa35-22a5477a71292025-10-17Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
ATOVAQUONEATOVAQUONEAvPAK4124ad97-f6b9-8afb-e063-6294a90ab9702025-10-14Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEATLANTIC BIOLOGICALS CORP.40331de7-819e-5965-e063-6294a90ac91d2025-10-01Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEKesin Pharma16b69156-e5de-c601-e063-6394a90afeae2025-09-15Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.